Tumor size reduction and serum CA 19-9 kinetics as metrics of resectability and response following neoadjuvant folfirinox in patients with pancreatic ductal adenocarcinoma
Year: 2023
Type: article
Source: HPB
Institution: Massachusetts General Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4381392208
